These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

87 related items for PubMed ID: 890692

  • 1. Clinical response and toxicity with cis-dichlorodiammineplatinum(II) in children.
    Kamalakar P, Freeman AI, Higby DJ, Wallace HJ, Sinks LF.
    Cancer Treat Rep; 1977 Aug; 61(5):835-9. PubMed ID: 890692
    [Abstract] [Full Text] [Related]

  • 2. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G, Marschke R, Camoriano JK, Sorensen JM, Sloan JA, Richardson RL.
    Cancer J Sci Am; 1997 Aug; 3(5):297-302. PubMed ID: 9327154
    [Abstract] [Full Text] [Related]

  • 3. cis-Dichlorodiammineplatinum (II) in advanced osteogenic sarcoma.
    Ochs JJ, Freeman AI, Douglass HO, Higby DS, Mindell ER, Sinks LF.
    Cancer Treat Rep; 1978 Feb; 62(2):239-45. PubMed ID: 346212
    [Abstract] [Full Text] [Related]

  • 4. cis-Dichlorodiammineplatinum(II) in childhood cancer.
    Freeman AI, Ettinger LJ, Brecher ML.
    Cancer Treat Rep; 1979 Feb; 63(9-10):1615-20. PubMed ID: 291483
    [Abstract] [Full Text] [Related]

  • 5. Clinical phase I-II study of cis-dichloro-diammineplatinum(II) given by continuous lv infusion.
    Salem P, Hall SW, Benjamin RS, Murphy WK, Wharton JT, Bodey GP.
    Cancer Treat Rep; 1978 Oct; 62(10):1553-5. PubMed ID: 361227
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of cis-dichlorodiammineplatinum(II) in children with advanced malignant diseases: Southwest Oncology Group Studies.
    Vietti TJ, Nitschke R, Starling KA, van Eys J.
    Cancer Treat Rep; 1979 Oct; 63(9-10):1611-4. PubMed ID: 291482
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pharmacokinetic evaluation of cisplatin in children with malignant solid tumors: a phase II study.
    Pratt CB, Hayes A, Green AA, Evans WE, Senzer N, Howarth CB, Ransom JL, Crom W.
    Cancer Treat Rep; 1981 Oct; 65(11-12):1021-6. PubMed ID: 7197583
    [Abstract] [Full Text] [Related]

  • 11. Phase II trail cisplatin in refractory childhood cancer: Children's Cancer Study Group Report.
    Baum ES, Gaynon P, Greenberg L, Krivit W, Hammond D.
    Cancer Treat Rep; 1981 Oct; 65(9-10):815-22. PubMed ID: 6944156
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Phase I study of a new antineoplastic agent, cis-diamminedichloroplatinum (II)].
    Gan To Kagaku Ryoho; 1982 Jan; 9(1):38-45. PubMed ID: 6892190
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Phase II study of cis-dichlorodiammineplatinum(II) in advanced breast cancer.
    Yap HY, Salem P, Hortobagyi GN, Bodey GP, Buzdar AU, Tashima CK, Blumenschein GR.
    Cancer Treat Rep; 1978 Mar; 62(3):405-8. PubMed ID: 348308
    [Abstract] [Full Text] [Related]

  • 19. Cisplatin, vindesine, mitomycin-C and 13-cis retinoic acid in the treatment of advanced non small cell lung cancer. A phase II pilot study.
    Recchia F, Sica G, De Filippis S, Rosselli M, Saggio G, Guerriero G, Pompili P, Rea S.
    Anticancer Res; 2000 Mar; 20(3B):1985-90. PubMed ID: 10928138
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.